Skip to main content

Table 1 Demographics and clinical features of the selected cohort

From: Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer’s disease continuum

Variable

Overall

SCD

MCI

pre-AD

MCI-AD

ADdem

FTD

n

233

52

30

19

50

45

37

Age (years) mean ± SD

70.5 ± 7.8

65.5 ± 9.0

71.0 ± 8.1

73.6 ± 5.8

72.5 ± 5.9

74.0 ± 6.4

68.4 ± 6.4

Sex (male) n (%)

99 (42.5)

28 (53.8)

14 (46.7)

6 (31.6)

16 (32.0)

15 (33.3)

20 (54.1)

MMSE median [IQR]

25.0 [22.0, 28.0]

28.0 [27.8, 29.0]

25.0 [23.2, 28.0]

27.0 [27.0, 28.5]

24.0 [22.0, 27.0]

15.0 [11.0, 19.0]

25.0 [23.0, 26.0]

Years of Education mean ± SD

9.4 ± 4.6

10.9 ± 4.3

9.0 ± 5.0

12.2 ± 3.5

9.1 ± 4.8

7.6 ± 3.8

9.5 ± 4.5

ATN profile, n (%)

 A-T-N-

73 (31.3)

38 (73.1)

17 (56.7)

0 (0.0)

0 (0.0)

0 (0.0)

18 (48.6)

 A + T-N-

14 (6.0)

3 (5.8)

4 (13.3)

0 (0.0)

0 (0.0)

1 (2.2)

6 (16.2)

 A + T + N-

14 (6.0)

0 (0.0)

0 (0.0)

7 (36.9)

7 (14.0)

0 (0.0)

0 (0.0)

 A + T + N + 

96 (41.2)

0 (0.0)

0 (0.0)

12 (63.2)

42 (84.0)

44 (97.8)

0 (0.0)

 A-T-N + 

5 (2.1)

1 (1.9)

2 (6.7)

0 (0.0)

0 (0.0)

0 (0.0)

2 (5.4)

 A-T + N-

15 (6.4)

6 (11.5)

5 (16.7)

0 (0.0)

0 (0.0)

0 (0.0)

4 (10.8)

 A-T + N + 

14 (7.0)

4 (7.7)

2 (6.7)

0 (0.0)

1 (2.0)

0 (0.0)

7 (18.9)

AD profile, n (%)

 Normal AD biomarkers

73 (31.3)

38 (73.1)

17 (56.7)

0 (0.0)

0 (0.0)

0 (0.0)

18 (48.6)

 AD pathologic change

14 (6.0)

3 (5.8)

4 (13.3)

0 (0.0)

0 (0.0)

1 (2.2)

6 (16.2)

 AD profile

112 (48.0)

0 (0.0)

0 (0.0)

19 (100.0)

49 (98.0)

44 (97.8)

0 (0.0)

 Non-AD pathologic change

34 (15.6)

11 (21.2)

9 (30.0)

0 (0.0)

1 (2.0)

0 (0.0)

13 (35.1)

  1. SCD Subjective cognitive decline MCI Mild cognitive impairment pre-AD preclinical Alzheimer’s disease MCI-AD Mild cognitive impairment due to Alzheimer’s disease ADdem Alzheimer’s disease with dementia, FTD Frontotemporal dementia IQR Interquartile range MMSE Mini-Mental State Examination SD Standard deviation